mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
6e-20 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
2e-14 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-12 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
2e-11 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-11 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-10 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
6e-10 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
1e-09 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-09 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-09 |